Rika Kasajima

584 total citations
37 papers, 350 citations indexed

About

Rika Kasajima is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Rika Kasajima has authored 37 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Rika Kasajima's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Neuroendocrine Tumor Research Advances (5 papers). Rika Kasajima is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Neuroendocrine Tumor Research Advances (5 papers). Rika Kasajima collaborates with scholars based in Japan, United States and United Kingdom. Rika Kasajima's co-authors include Yohei Miyagi, Satoru Miyano, Seiya Imoto, Kazuaki Yokoyama, Tomoyuki Yokose, Eigo Shimizu, Rui Yamaguchi, Mika Ito, Arinobu Tojo and Asako Kobayashi and has published in prestigious journals such as Blood, Scientific Reports and Annals of Oncology.

In The Last Decade

Rika Kasajima

35 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rika Kasajima Japan	10	133	129	126	90	71	37	350
Alexander B. Sibley United States	12	171 1.3×	124 1.0×	71 0.6×	80 0.9×	100 1.4×	27	393
Manali Rupji United States	13	165 1.2×	186 1.4×	76 0.6×	111 1.2×	59 0.8×	45	479
Maxime Chénard-Poirier United Kingdom	11	178 1.3×	144 1.1×	79 0.6×	83 0.9×	34 0.5×	30	355
Jérôme Alexandre France	3	139 1.0×	296 2.3×	78 0.6×	174 1.9×	30 0.4×	4	445
Hiroyuki Maeta Japan	11	146 1.1×	191 1.5×	96 0.8×	79 0.9×	23 0.3×	24	419
Qirong Geng China	12	112 0.8×	172 1.3×	117 0.9×	158 1.8×	32 0.5×	27	469
Maoxiang Qian China	11	118 0.9×	315 2.4×	93 0.7×	77 0.9×	189 2.7×	43	516
Tristan Maurina France	10	108 0.8×	118 0.9×	73 0.6×	154 1.7×	17 0.2×	30	293
Ki Sun Jung South Korea	10	146 1.1×	201 1.6×	82 0.7×	153 1.7×	15 0.2×	21	347
Ryuji Nakano Japan	10	139 1.0×	131 1.0×	155 1.2×	48 0.5×	36 0.5×	26	363

Countries citing papers authored by Rika Kasajima

Since Specialization

Citations

This map shows the geographic impact of Rika Kasajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Kasajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Kasajima more than expected).

Fields of papers citing papers by Rika Kasajima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Kasajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Kasajima. The network helps show where Rika Kasajima may publish in the future.

Co-authorship network of co-authors of Rika Kasajima

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Kasajima. A scholar is included among the top collaborators of Rika Kasajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Kasajima. Rika Kasajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okubo, Yoichiro, Rika Kasajima, Shinya Sato, et al.. (2025). Cribriform pattern and IDC ‐P in prostate biopsies: prognostic relevance and reporting in metastatic disease. The Journal of Pathology Clinical Research. 11(6). e70052–e70052.

Kasajima, Rika, Koichi Azuma, Tomoyuki Tagami, et al.. (2024). Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma. Frontiers in Immunology. 15. 1361992–1361992. 3 indexed citations

Kuwatsuka, Yachiyo, Rika Kasajima, Rui Yamaguchi, et al.. (2024). Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation. Transplantation and Cellular Therapy. 30(4). 444.e1–444.e11. 1 indexed citations

Kouro, Taku, Yasunobu Mano, Rika Kasajima, et al.. (2024). Novel chimeric antigen receptor‐expressing T cells targeting the malignant mesothelioma‐specific antigen sialylated HEG1. International Journal of Cancer. 154(10). 1828–1841. 5 indexed citations

Okubo, Yoichiro, Rika Kasajima, Soji Toda, et al.. (2024). Effective Preparation of FFPE Tissue Samples for Preserving Appropriate Nucleic Acid Quality for Genomic Analysis in Thyroid Carcinoma. Endocrine Pathology. 35(4). 372–384. 5 indexed citations

Sato, Shinya, Toru Hiruma, Mitsuyo Yoshihara, et al.. (2023). Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Cancer Science. 114(6). 2674–2688. 17 indexed citations

Washimi, Kota, Yukihiko Hiroshima, Rika Kasajima, et al.. (2023). Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling. Diagnostic Pathology. 18(1). 5–5. 3 indexed citations

Washimi, Kota, Rika Kasajima, Shinya Sato, et al.. (2023). Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma. Scientific Reports. 13(1). 6744–6744. 2 indexed citations

Kawachi, Kae, Xiaoyan Tang, Rika Kasajima, et al.. (2023). Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma. Breast Cancer Research and Treatment. 202(3). 563–573. 3 indexed citations

10.

Suzuki, Masaki, Rika Kasajima, Tomoyuki Yokose, et al.. (2023). KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component. Translational Lung Cancer Research. 12(8). 1738–1751. 2 indexed citations

11.

Yokoyama, Kazuaki, Masahiko Sumi, Ichiro Ito, et al.. (2022). Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia. Frontiers in Oncology. 12. 974307–974307. 2 indexed citations

12.

Yada, Erica, Rika Kasajima, Atsushi Niida, et al.. (2021). Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. Biomedicines. 9(10). 1396–1396. 15 indexed citations

13.

Suzuki, Masaki, Rika Kasajima, Tomoyuki Yokose, et al.. (2021). Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component. Translational Lung Cancer Research. 10(3). 1292–1304. 10 indexed citations

14.

Yokoyama, Kazuaki, Eigo Shimizu, Miho Ogawa, et al.. (2019). Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDS. Blood. 133(25). 2682–2695. 71 indexed citations

15.

Hiroshima, Yukihiko, Rika Kasajima, Yayoi Kimura, et al.. (2019). Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters. 469. 217–227. 18 indexed citations

16.

Yokoyama, Kazuaki, Eigo Shimizu, Rika Kasajima, et al.. (2018). Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes. Blood Advances. 2(19). 2513–2521. 8 indexed citations

17.

Okubo, Yoichiro, Rika Kasajima, Masaki Suzuki, et al.. (2017). Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: a retrospective study. BMC Cancer. 17(1). 769–769. 6 indexed citations

18.

Okubo, Yoichiro, Osamu Motohashi, Norisuke Nakayama, et al.. (2016). The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure. Diagnostic Pathology. 11(1). 128–128. 12 indexed citations

19.

Kasajima, Rika, et al.. (2016). Combined large cell neuroendocrine carcinoma and endometrioid carcinoma of the endometrium: a shared gene mutation signature between the two histological components. International Cancer Conference Journal. 6(1). 11–15. 9 indexed citations

20.

Kikuchi, Keiji, Akira Noguchi, Rika Kasajima, et al.. (2015). Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma. Tumor Biology. 36(10). 7865–7872. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact